Our other therapy areas

    • {%itemName%}
        {%brandMenuItems%}
    • {%itemName%} {%arrowSpan%}
        {%subBrandMenuItems%}
    • {%itemName%} {%arrowSpan%}
        {%productMenuItems%}
    • {%itemKeyName%} {%itemBadges%} {%arrowSpan%}
      {%selfProduct%}
    • {%itemName%}
      • {%countries%}
    • {%allMenuItem%}
      • {%languages%}

      • This website is for Israeli Healthcare Professionals only

      View Leading Experts Presentations

      Watch Dr. Matti Waterman, Prof. Ariella Bar-Gil Shitrit & Dr. Irit Avni Biron speak about new modes of action in IBD & AbbVie’s future molecules.

      Duration 22:08

      New molecules for IBD
      Dr. Irit Avni Biron

      Duration 22:57

      AbbVie's future molecules in IBD 
      Prof. Ariella Bar-Gil Shitrit

      Duration 22:24

      New MOA & AbbVie’s pipeline in IBD
      Dr. Matti Waterman

      FPO

      AbbVie’s Symposia Agenda

      For ECCO registered attendees, the induction results of Risankizumab in CD and Upadacitinib in UC are available in the scientific program (oral presentations), and as part of Abbvie's symposia.

      To view AbbVie’s symposia agenda click here

       

       

       

      RISN-IL-00007-MC